BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 29444188)

  • 1. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
    Kagdi HH; Demontis MA; Fields PA; Ramos JC; Bangham CR; Taylor GP
    Cancer Med; 2017 Jan; 6(1):298-309. PubMed ID: 28035765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
    Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
    Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.
    Satou Y; Utsunomiya A; Tanabe J; Nakagawa M; Nosaka K; Matsuoka M
    Retrovirology; 2012 May; 9():46. PubMed ID: 22647666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
    Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
    Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.
    Manuel SL; Sehgal M; Connolly J; Makedonas G; Khan ZK; Gardner J; Betts MR; Jain P
    J Clin Immunol; 2013 Oct; 33(7):1223-39. PubMed ID: 23888327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
    Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
    Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
    Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
    PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia.
    Ishihara M; Araya N; Sato T; Tatsuguchi A; Saichi N; Utsunomiya A; Nakamura Y; Nakagawa H; Yamano Y; Ueda K
    Blood; 2013 May; 121(21):4340-7. PubMed ID: 23538341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia.
    Hata T; Fujimoto T; Tsushima H; Murata K; Tsukasaki K; Atogami S; Sohda H; Honda S; Mine M; Yamada Y; Ikeda S; Kamihira S; Tomonaga M
    Leukemia; 1999 Feb; 13(2):215-21. PubMed ID: 10025895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.